Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D

{
  "signal_id": "a4779e62-9a09-168d-2bf0-b97166ad39c1",
  "signal_type": "news",
  "signal_subtype": "signs_new_client",
  "detected_at": "2026-08-17T02:00:00+00:00",
  "company": {
    "name": "Cognizant",
    "domain": "cognizant.com"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/cognizant-and-benchling-selected-as-partners-to-accelerate-kyowa-kirins-rd-302851839.html",
    "title": "Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D",
    "excerpt": "Transforming the Research Lifecycle Through Integrated Data Management, Advanced Automation, and AI-Driven Workflows TOKYO , Aug. 16, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH ) today announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Research Park, research sites in Japan operated by Kyowa Kirin Co., Ltd. Benchling gives scientists a single place to capture structured data, run AI models and agents and automate the workflows that move discovery and development forward. Through Cognizant's implementation support, researchers in the Research Division of Kyowa Kirin will be able to efficiently and seamlessly conduct a range of research activities, from experiment planning and execution to data collection and use of AI, within a single environment. This implementation demonstrates Kyowa Kirin's strong commitment to accelerating R&D productivity by addressing an expanding pipeline and increasingly advanced and diverse research needs. Cognizant will support this effort through centralized data management, enhanced molecular design processes and workflow automation. Kyowa Kirin is a global specialty pharmaceutical company with strengths in specific disease areas, including bone and mineral disorders, intractable hematologic diseases and hemato oncology and rare diseases. At its three research...",
    "summary": "Kyowa Kirin has selected Cognizant to support the introduction and implementation of Benchling's AI platform for R&D at its research parks in Japan.",
    "location": "Japan",
    "planning": true,
    "image_url": "https://mmx.prnewswire.com/media/MS607279/Cognizant-Logo-V1.jpg?id=OA2887226&p=facebook",
    "confidence": 0.9,
    "published_at": "2026-08-17T02:00:00Z",
    "location_data": [
      {
        "region": "Eastern Asia",
        "country": "Japan",
        "continent": "Asia",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "16, 2026 /PRNewswire/ -- Cognizant (NASDAQ: CTSH ) today announced that it will support the introduction and implementation of Benchling, the AI platform for R&D at Tokyo Research Park and Fuji Research Park, research sites in Japan operated by Kyowa Kirin Co., Ltd.",
    "related_company_name": "Kyowa Kirin Co., Ltd.",
    "related_company_domain": "kyowakirin.com"
  }
}

curl https://signals.autobound.ai/v1/signals/a4779e62-9a09-168d-2bf0-b97166ad39c1 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"cognizant.com","limit":20}'